Abdominal aortic calcification: Clinical significance, mechanisms and therapies

Current Pharmaceutical Design

Volumn 20, Issue 37, 2014, Pages 5834-5838

  Golledge, Jonathan ^a,b  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Abdominal aortic calcification; Aorta; Calcification; Cardiovascular events

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PHOSPHATE BINDING AGENT; SIMVASTATIN; VITAMIN B GROUP;

ABDOMINAL AORTIC CALCIFICATION; AGE; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DEATH; DISEASE SEVERITY; HUMAN; INCIDENCE; NONHUMAN; OSTEOPOROSIS; RISK FACTOR; ABDOMINAL AORTA; DRUG EFFECTS; METABOLISM; PATHOLOGY; VASCULAR CALCIFICATION;

AORTA, ABDOMINAL; HUMANS; VASCULAR CALCIFICATION;

EID: 84911466828     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140212195309     Document Type: Article

References (58)

1. Kramer CK, Zinman B, Gross JL, et al. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ 2013; 346: f1654.
2. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg 2005; 30: 476-88.
3. Liu F, Fu P, Fan W, et al. Involvement of parathyroid hormone-related protein in vascular calcification of chronic haemodialysis patients. Nephrology (Carlton) 2012; 17: 552-60.
4. Pal SN, Rush C, Parr A, Van Campenhout A, Golledge J. Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis 2010; 210: 88-93.
5. Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 2012; 14: 228-37.
6. Van Campenhout A, Moran CS, Parr A, et al. Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis 2009; 202: 557-66.
7. Golledge J, Jayalath R, Oliver L, Parr A, Schurgers L, Clancy P. Relationship between CT anthropometric measurements, adipoki-nes and abdominal aortic calcification. Atherosclerosis 2008; 197: 428-34.
8. Pencak P, Czerwieńska B, Ficek R, et al. Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol 2013; 14: 10.
9. El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I. Relationship between vertebral fracture prevalence and abdominal aortic calcification in men. Rheumatology (Oxford) 2012; 51: 1714-20.
10. Simon SP, Fodor D, Muntean L, Poanta L, Cristea P, Rednic S. Bone mineral density, vertebral fractures and body mass index in postmenopausal women with abdominal aortic calcification. Endocr Res 2013 May 7. [Epub ahead of print].
11. Figueiredo CP, Rajamannan NM, Lopes JB, et al. Serum phosphate and hip bone mineral density as additional factors for high vascular calcification scores in a community-dwelling: the São Paulo Ageing & Health Study (SPAH). Bone 2013; 52: 354-9.
12. Yamada K, Fujimoto S, Nishiura R, et al. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transplant 2007; 22: 2032-7.
13. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison MA. Blood pressure and vascular calcification. Hypertension 2010; 55: 990-7.
14. Clancy P, Oliver L, Jayalath R, Buttner P, Golledge J. Assessment of a serum assay for quantification of abdominal aortic calcification. Arterioscler Thromb Vasc Biol 2006; 26: 2574-6.
15. Van Campenhout A, Clancy P, Golledge J. Serum osteoprotegerin as a biomarker for vascular disease. Am J Cardiol 2007; 100: 561.
16. Van Campenhout A, Moran CS, Parr A, et al. Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis 2009; 202: 557-66.
17. Ishimura E, Okuno S, Kitatani K, et al. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol 2004; 24: 408-12.
18. Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 2679-85.
19. Cecelja M, Hussain T, Greil G, et al. Multimodality imaging of subclinical aortic atherosclerosis: relation of aortic stiffness to calcification and plaque in female twins. Hypertension 2013; 61: 609-14.
20. Pal SN, Clancy P, Golledge J. Circulating concentrations of stem-cell-mobilizing cytokines are associated with levels of osteopro-genitor cells and aortic calcification severity. Circ J 2011; 75: 1227-34.
21. Ogawa-Furuya N, Yamaguchi T, Yamamoto M, Kanazawa I, Su-gimoto T. Serum osteocalcin levels are inversely associated with abdominal aortic calcification in men with type 2 diabetes mellitus. Osteoporos Int 2013; 24: 2223-30.
22. Szulc P, Hofbauer LC, Rauner M, Goettsch C, Chapurlat R, Schoppet M. Serum myostatin levels are negatively associated with abdominal aortic calcification in older men: the STRAMBO study. Eur J Endocrinol 2012; 167: 873-80.
23. Cozzolino M, Galassi A, Biondi ML, et al. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol 2006; 26: 423-9.
24. Pal SN, Golledge J. Osteo-progenitors in vascular calcification: a circulating cell theory. J Atheroscler Thromb 2011; 18: 551-9.
25. Golledge J, Van Campenhout A, Pal S, Rush C. Bone marrow-derived cells and arterial disease. J Vasc Surg 2007; 46: 590-600.
26. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-35.
27. Shigematsu T, Kono T, Satoh K, et al. Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transplant 2003; 18 Suppl 3: iii86-9.
28. Du Y, Wang Y, Wang L, et al. Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ Res 2011; 108: 917-28.
29. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386(6620): 78-81.
30. Westenfeld R, Schäfer C, Krüger T, et al. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 2009; 20: 1264-74.
31. Chu Y, Lund DD, Weiss RM, et al. Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler Thromb Vasc Biol 2013; 33: 523-32.
32. Speer MY, Chien YC, Quan M, et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005; 66: 324-33.
33. Komaba H, Fukagawa M. Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification? Kidney Int 2012; 82: 1248-50.
34. Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F, Stangl GI. Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 2012; 7: e35316.
35. Sasaki T, Nakamura K, Sasada K, et al. Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice. Atherosclerosis 2013; 227: 43-50.
36. Idelevich A, Rais Y, Monsonego-Ornan E. Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol 2011; 31: e55-71.
37. Cecil DL, Terkeltaub RA. Arterial calcification is driven by RAGE in Enpp1-/-mice. J Vasc Res 2011; 48: 227-35.
38. Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apol-ipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2009; 29: 2069-75.
39. Yoon HE, Park BG, Hwang HS, et al. The prognostic value of abdominal aortic calcification in peritoneal dialysis patients. Int Med Sci 2013; 10: 617-23.
40. Ohya M, Otani H, Kimura K, et al. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol 2011; 15: 877-83.
41. Nielsen M, Ganz M, Lauze F, et al. Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women. BMC Cardiovasc Disord 2010; 10: 56.
42. Verbeke F, Van Biesen W, Honkanen E, et al. CORD Study Investigators. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011; 6: 153-9.
43. Parr A, Buttner P, Shahzad A, Golledge J. Relation of infra-renal abdominal aortic calcific deposits and cardiovascular events in patients with peripheral artery disease. Am J Cardiol 2010; 105: 895-9.
44. Hanada S, Ando R, Naito S, et al. Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 2010; 25: 1888-95.
45. Bolland MJ, Wang TK, van Pelt NC, et al. Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 2010; 25: 505-12.
46. Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007; 49: 417-25.
47. Rodondi N, Taylor BC, Bauer DC, et al. Association between aortic calcification and total and cardiovascular mortality in older women. J Intern Med. 2007; 261: 238-44.
48. Harbaugh CM, Terjimanian MN, Lee JS, et al. Abdominal aortic calcification and surgical outcomes in patients with no known cardiovascular risk factors. Ann Surg 2013; 257: 774-81.
49. Block GA, Wheeler DC, Persky MS, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012; 23: 1407-15.
50. Saremi A, Moritz TE, Anderson RJ, et al. Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care 2010; 33: 2642-7.
51. Wang TK, Bolland MJ, van Pelt NC, et al. Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J Bone Miner Res 2010; 25: 2777-85.
52. Hodis HN, Mack WJ, Dustin L, et al. High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial. Stroke 2009; 40: 730-6.
53. Takei T, Otsubo S, Uchida K, et al. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemo-dialysis. Nephron Clin Pract 2008; 108: c278-83.
54. Terry JG, Carr JJ, Kouba EO, et al. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol 2007; 99: 1714-7.
55. Ariyoshi T, Eishi K, Sakamoto I, Matsukuma S, Odate T. Effect of etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig 2006; 26: 215-22.
56. Arai Y, Hirose N, Yamamura K, et al. Long-term effect of lipid-lowering therapy on atherosclerosis of abdominal aorta in patients with hypercholesterolemia: noninvasive evaluation by a new image analysis program. Angiology. 2002; 53: 57-68.
57. Hotta K, Harada H, Sasaki H, et al. Successful kidney transplantation ameliorates arterial stiffness in end-stage renal disease patients. Transplant Proc 2012; 44: 684-6.
58. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71: 802-7.